TAVI: 60 Second Insights
Published: 28 March 2018
-
Views:
394
-
Likes:
7
-
Views:
394
-
Likes:
7
-
Up Next
-
29sPart 7 | Session 1 Nicolas Van Mieghem
-
1mPart 7 | Session 2 Francesco Maisano
-
18sPart 8 | Session 1 Nicolas Van Mieghem
-
1m 10sPart 8 | Session 2 Francesco Maisano
-
36sPart 1 | Session 1 Nicolas Van Mieghem Nicolas M Van Mieghem
-
1m 2sPart 1 | Session 2 Francesco Maisano Francesco Maisano
-
28sPart 2 | Session 1 Nicolas Van Mieghem Nicolas M Van Mieghem
-
55sPart 2 | Session 2 Francesco Maisano Francesco Maisano
-
31sPart 3 | Session 1 Nicolas Van Mieghem Nicolas M Van Mieghem
-
1m 8sPart 3 | Session 2 Francesco Maisano Francesco Maisano
-
25sPart 4 | Session 1 Nicolas Van Mieghem Nicolas M Van Mieghem
-
1m 2sPart 4 | Session 2 Francesco Maisano Francesco Maisano
-
20sPart 5 | Session 1 Nicolas Van Mieghem Nicolas M Van Mieghem
-
1m 5sPart 5 | Session 2 Francesco Maisano Francesco Maisano
-
37sPart 6 | Session 1 Nicolas Van Mieghem Nicolas M Van Mieghem
Overview
A short series of 60-second insight videos on TAVI.
More from this programme
Part 1
Do you think it is necessary to perform coronary revascularisation pre-TAVR? Do you use FFR/iFR decision-making?
| 2 sessions | |
| Nicolas Van Mieghem | Watch now |
| Francesco Maisano | Watch now |
Part 2
Are we ready to be doing TAVR in low risk patients?
| 2 sessions | |
| Nicolas Van Mieghem | Watch now |
| Francesco Maisano | Watch now |
Part 3
Which patients are you performing TAVR in now (High/Medium risk)?
| 2 sessions | |
| Nicolas Van Mieghem | Watch now |
| Francesco Maisano | Watch now |
Part 4
Which is your preferred valve, and why?
| 2 sessions | |
| Nicolas Van Mieghem | Watch now |
| Francesco Maisano | Watch now |
Part 5
How would you recommend someone start a TAVR program?
| 2 sessions | |
| Nicolas Van Mieghem | Watch now |
| Francesco Maisano | Watch now |
Part 6
What is the most important clinical trial data and why?
| 2 sessions | |
| Nicolas Van Mieghem | Watch now |
| Francesco Maisano | Watch now |
Part 7
What is the biggest innovation in TAVR over the past 12-24 months?
| 2 sessions | |
| Nicolas Van Mieghem | Watch now |
| Francesco Maisano | Watch now |
Part 8
What proportion of your patients have a TAVR rather than and surgical AVR?
| 2 sessions | |
| Nicolas Van Mieghem | Watch now |
| Francesco Maisano | Watch now |
Faculty Biographies
Francesco Maisano
Head of Cardiac Surgery, Director of the Valve Center
Prof Maisano is Professor of Cardiac Surgery and Director of the Valve Center at San Raffaele Research Hospital in Milan.
Prof Maisano is a cardiac surgeon with large experience in standard cardiovascular treatments and innovative technologies, as well as cross-trained in interventional cardiology, with specific focus on structural interventions.
In his research, Prof Maisano was the principal investigator of the ACCESS EU Registry, the largest European registry monitoring the real-world results of MitraClip therapy. He is the co-inventor of a surgical annular prosthesis, which is now a standard surgical technique in the treatment of functional mitral valve regurgitation.
Prof Maisano is an Editorial Board member of Cardiac Failure Review.